SBI Contra Fund

You might also like

Download as pdf or txt
Download as pdf or txt
You are on page 1of 1

SBI Contra Fund (Regular Plan)

PRODUCT RISK RATING 3 Contra


31-May-2023

No of
Fund Manager Dinesh Balachandran 77
Holdings
1 Year 3 Years
Expense Category Category
Category benchmark S&P BSE 500 TRI 1.85 Fund Fund
Ratio (%) benchmark benchmark
Month-end AUM in Inception Sharpe Ratio 1.38 0.54 2.23 1.39
10,565 6-May-05
Rs. Crs* Date Volatility (Std Dev) 10.56% 12.35% 14.62% 15.40%

Performance Section Calendar Year Performance %


Trailing Point to Point Category Peer Group 60
Fund
Returns (%) benchmark Average 49.9
50
3 months 8.11 8.92 7.65
40 36.0
6 months 4.21 -0.83 1.71 31.6 30.6
1 year 22.48 12.85 16.05 30
18.4
3 years 43.15 27.95 29.58 20 15.2
12.8
5 years 16.34 12.58 10.79 10 6.2
2.4 4.1 4.8 5.9
Inception 16.10 NA 13.64
0
Rolling Return Performance (%) YTD 2022 2021 2020
3 years 20.19 15.35 13.24
5 years 11.43 12.85 12.24 Fund Category benchmark Peer Group
Returns less than 1 year are absolute, while > = 1 year are annualised
Peer Group Average represented by Value Fund universe

Market Cap Classification (% to NAV) Trailing SIP Performance (based on monthly investment of Rs 10000)
1 year 3 years 5 years 10 years
Cash and others Large Cap Investment value (Rs)
YTD 20.68% 6.25 2.39 38.34%4.05 Fund 133,004 535,618 1,108,582 2,900,695
2022 12.76 4.77 5.87 Category benchmark 127,971 452,457 889,419 2,482,082
2021 49.92 31.63 36.03
2020 Small-Cap 30.60 18.41 15.16 SIP Returns (%)
Mid-Cap
19.79% 21.19% Fund 20.79 27.64 24.84 16.83
Category benchmark 12.61 15.45 15.76 13.92

Top 5 Holdings * Sector Allocation (% to NAV) *


Company Name % to NAV
GAIL (India) Ltd. 3.69 Financials 19.6
21.0
ICICI Bank Ltd. 2.82
Industrials 10.1
Equitas Small Finance Bank Ltd. 2.45 8.4
HDFC Bank Ltd. 2.20 Utilities 9.5
Axis Bank Ltd. 2.17 9.8
Materials 9.2
Total Top 05 13.33 7.9
Health Care 6.7
4.5
0 5 10 15 20 25
May-23 3 Months Ago (Feb'23)

Notes
Exit load of the fund: (Period 0 days to 365 days) 1%

Market cap classification - Top 100 stocks based on market cap is considered as largecap, next top 150 stocks is considered as midcap
and all stocks below that is small-cap
Source: CRISIL

Disclaimer
The report and information contained herein is of confidential nature and meant only for the selected recipient and should not be altered in any way, transmitted to, copied or distributed, in any manner and form, to any other person or to the media or reproduced in any form, without
prior written approval of State Bank of India. The material in this document/report is based on facts, figures and information that are obtained from publicly available media or other sources believed to be reliable and hence considered true, correct, reliable and accurate but State Bank of
India does not guarantee or represent (expressly or impliedly) that the same are true, correct, reliable and accurate, not misleading or as to its genuineness, fitness for the purpose intended and it should not be relied upon as such. State Bank of India does not in any way through this
material solicit any offer for purchase, sale or entering into any financial transaction/commodities/products of any financial instrument dealt in this material. All recipients of this material should before dealing and or transacting in any of the products referred to in this material make their
own investigation, and seek appropriate professional advice
Prospective investors and others are cautioned and should be alert that any forward-looking statements are not predictions and may be subject to change without providing any notice. Actual results may differ materially from those suggested by the forward looking statements due to
risks or uncertainties associated with our expectations with respect to, but not limited to, exposure to market risks, general economic and political conditions in India and other countries globally, which have an impact on our services and / or investments, the monetary and interest
policies of India, inflation, deflation, unanticipated turbulence in interest rates, foreign exchange rates, equity prices or other rates or prices, the performance of the financial markets in India and globally, changes in domestic and foreign laws, regulations and taxes and changes in
competition in the industry. By their nature, certain market risk disclosures are only estimates and could be materially different from what actually occurs in the future. As a result, actual future gains or losses could materially differ from those that have been estimated.
State Bank of India (including its subsidiaries) and any of its officers directors, personnel and employees, shall not liable for any loss, damage of any nature, including but not limited to direct, indirect, punitive, special, exemplary, consequential, as also any loss of profit in any way arising
from the use of this material in any manner and any action on decision taking to buy, sale, invest, subscribe or entering into any contract for any financial product or services.
The recipient alone shall be fully responsible/ are liable for any decision taken on the basis of this material. The investments discussed in this material may not be suitable for all investors. Any person subscribing to or investing in any product/financial instruments should do so on the basis
of and after verifying the terms attached to such product/financial instrument. Financial products and instruments, are subject to market risks and yields may fluctuate depending on various factors affecting capital/debt markets. Please note that past performance of the financial products
and instruments does not necessarily indicate the future prospects and performance thereof. Such past performance may or may not be sustained in future. State Bank of India (including its subsidiaries) or its officers, directors, personnel and employees, including persons involved in the
preparation or issuance of this material may; (a) from time to time, have long or short positions in, and buy or sell the securities mentioned herein or (b) be engaged in any other transaction involving such securities and earn brokerage or other compensation in the financial
instruments/products/commodities discussed herein or act as advisor or lender / borrower in respect of such securities/financial instruments/products/commodities or have other potential conflict of interest with respect to any recommendation and related information and opinions. The
said persons may have acted upon and/or in a manner which is in conflict with the information contained here. Purchase of any Insurance product by a Bank's Customer, is purely voluntary in nature and is not linked to any other facility from the Bank. Mutual Fund and all Financial
investments are subject to market risks. Please read the offer document and scheme related information carefully before investing.

You might also like